Package 0409-1144-02

{"route": ["INTRAVENOUS"], "spl_id": "7af1aa07-d2f6-4f67-966f-b8a702ee3efb", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["898316", "1665057", "1665061"], "spl_set_id": ["1c993365-1b62-4524-e781-d307f28f63bc"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 VIAL in 1 CARTON (0409-1144-02)  / 4 mL in 1 VIAL (0409-1144-62)", "package_ndc": "0409-1144-02", "marketing_start_date": "20050430"}, {"sample": false, "description": "25 VIAL in 1 CARTON (0409-1144-05)  / 2 mL in 1 VIAL (0409-1144-65)", "package_ndc": "0409-1144-05", "marketing_start_date": "20110202"}], "brand_name": "Verapamil Hydrochloride", "product_id": "0409-1144_7af1aa07-d2f6-4f67-966f-b8a702ee3efb", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "0409-1144", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA070737", "marketing_category": "ANDA", "marketing_start_date": "20050331", "listing_expiration_date": "20261231"}